CV Technologies Inc. (TSX:CVQ) - maker of COLD-fXTM - today announced a multi-year partnership with the National Hockey League (NHL®) and the National Hockey League Players’ Association (NHLPA) to promote COLD-fX in the United States and Canada. Already the # 1 selling cold and flu product in Canada according to ACNielsen(i), COLD-fX will leverage its affiliation with the NHL, the NHLPA and former NHL superstar, Mark Messier, for a scheduled launch this fall in the U.S. as an immune enhancer.
